Phostensin inhibitors belong to a class of chemical compounds designed to selectively target and modulate the activity of the protein known as phostensin. Phostensin, also referred to as phosphatase 1 nuclear targeting subunit (PNUTS), is a regulatory protein that plays a critical role in cellular processes related to protein phosphorylation and dephosphorylation. Phostensin is known for its interaction with protein phosphatase 1 (PP1), a crucial enzyme that regulates a wide range of cellular functions by dephosphorylating target proteins. The interaction between phostensin and PP1 is essential for controlling the activity and substrate specificity of PP1. Phostensin inhibitors are developed through chemical synthesis and structural optimization techniques, with the primary goal of interacting with specific domains or functional motifs of the phostensin protein to influence its interactions with PP1 and other cellular processes related to protein phosphorylation.
The design of phostensin inhibitors typically involves creating molecules that can selectively bind to phostensin, potentially disrupting its interactions with PP1 or modulating its regulatory functions. By modulating phostensin activity, these inhibitors can potentially impact protein dephosphorylation and, in turn, affect various cellular processes that rely on precise protein phosphorylation states, such as cell cycle regulation, DNA repair, and signal transduction. The study of phostensin inhibitors provides valuable insights into the intricate molecular mechanisms governing protein phosphorylation and dephosphorylation, offering a deeper understanding of the fundamental processes that underlie cellular signaling and regulation. This research advances our knowledge of basic cell biology and the regulatory networks that maintain cellular homeostasis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Incorporated into RNA and DNA and may disrupt methylation, potentially reducing gene expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
A uracil analog that interferes with nucleotide synthesis and can inhibit mRNA production. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Exhibits anti-inflammatory properties and can downregulate transcription factors, possibly affecting gene expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor that can affect various signaling pathways and potentially downregulate gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Inhibits histone deacetylases, affecting chromatin structure and gene expression. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
Inhibits BET bromodomains, possibly leading to alterations in chromatin structure and gene transcription. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
Selectively inhibits class I histone deacetylases, altering gene expression. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Inhibits cyclin-dependent kinases (CDKs) and can affect transcription regulation. | ||||||
Temozolomide | 85622-93-1 | sc-203292 sc-203292A | 25 mg 100 mg | $89.00 $250.00 | 32 | |
Alkylates/methylates DNA, which can lead to mismatch repair and downregulation of gene expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Interacts with DNA and inhibits the elongation phase of RNA polymerase, decreasing gene expression. | ||||||